We examined the anticancer effects of spironolactone, a classic potassium-sparing diuretic that is used for cancer patients with ascites, hypertension induced by anti-VEGF therapy, and brain edema related to brain tumors, from the perspective of drug repositioning or repurposing. Here, VEGFA is linked to Hypertension.